UAA
NYSE · Textiles, Apparel & Luxury Goods
Under Armour Inc-Class A
$6.43
+0.04 (+0.63%)
UAA News30 articles
Nike Stock Volatile After Supreme Court Tariff Ruling; Earnings Loom
Nike stock closed slightly lower after an 8% intraday swing following a Supreme Court tariff ruling. Investors now focus on a new 10% global tariff effective Tuesday and the company's upcoming March 19 earnings report.
Nike Shares Slide Below Key Technical Levels Amid Focus on Upcoming Product Launches
Nike shares declined 1.1% in extended trading Wednesday, falling below critical 50- and 200-day moving averages. Investors are monitoring upcoming Jordan Brand and Levi's collaborations for demand signals.
Nubank's Credit Expansion Under Scrutiny as Nu Holdings Shares Slide Pre-Earnings
Nu Holdings shares dropped 3.23% to $13.80 before Nubank's Q1 earnings. Investors focus on credit quality and costs amid expansion.
McCormick Stock Plunges 35% in a Year; DCF Suggests 57.5% Undervaluation
McCormick & Company shares have dropped 35.3% in the past year, closing at $47.90. A DCF analysis, however, estimates an intrinsic value of $112.76, pointing to a potential 57.5% undervaluation.
Teradyne Lifts Dividend as AI Test Demand Sustainability Under Scrutiny
Teradyne announced a $0.13 quarterly dividend, payable June 12. Shares rose 1.8% after an 87% Q1 revenue surge to $1.282B, fueled by AI testing demand, but concerns persist about sustainability.
IREN Stock Rises Ahead of Q3 Earnings; Mirantis Deal and AI Pivot Under Scrutiny
IREN Ltd. shares rose 1.6% to $61.94 ahead of fiscal Q3 earnings, with focus on AI cloud revenue from its $625M Mirantis deal and the new Sweetwater 1 data center.
McDonald's Q1 Earnings Beat: Value Strategy Under Scrutiny as U.S. Traffic Wavers
McDonald's beat Q1 earnings estimates with revenue up 9% to $6.517B, but U.S. same-store sales missed targets and traffic was uneven, testing value meal strategy.
Figma Stock Under Pressure as AI Strategy Faces First Major Test
Figma shares trade near $20 ahead of May 14 earnings, with investors focused on whether AI features can drive revenue growth amid rising costs and analyst caution.
Oil Surge and Geopolitical Risk Rattle Wall Street, UBS Warns of Underestimated Impact
Brent crude surged 5.8% to $114.44 after new attacks in the Strait of Hormuz, while the S&P 500 fell 0.41%. UBS warns investors are missing the bigger risk of sustained economic damage.
Palantir Earnings: AI Pricing Power and Growth Under the Microscope
Palantir reports Q1 earnings Monday with options pricing a 9% swing. Focus on AI platform demand, government contracts, and pricing power as analysts diverge.
Eaton's Q1 Earnings Test: AI Data Center Demand Under Microscope
Eaton reports Q1 results Tuesday, with Wall Street watching AI data center orders, margins, and the Boyd Thermal acquisition for signs of sustained growth.
IonQ Q1 Earnings Preview: Revenue Targets and SkyWater Deal Under Scrutiny
IonQ reports Q1 earnings May 6 with $48-$51M revenue guidance and up to $330M adjusted EBITDA loss. SkyWater acquisition faces FTC review.
MaxLinear's AI Data-Center Pivot Under Pressure as Stock Surges Past Analyst Targets
MaxLinear shares surged 9.1% to $77.18 after infrastructure revenue overtook broadband, driven by AI data-center chips. But the stock now trades above analyst targets, raising execution and valuation concerns.
Keel Infrastructure Nears First Earnings Report Under KEEL Ticker
Keel Infrastructure Corp. will release its first-quarter earnings on May 11, marking its initial report under the KEEL ticker following Bitfarms' redomiciliation.
Recursion Pharma Co-Founder Gibson to Exit Board Ahead of Q1 Results
Recursion Pharmaceuticals founder Chris Gibson will leave the board at the June annual meeting. Q1 earnings due May 6; focus on cash, clinical progress, and AI platform.
Q2 2026 Growth Stocks: Big Tech's AI Spending Under Scrutiny
Big Tech earnings this week will reveal if heavy AI investment is driving growth. Visa, T-Mobile, FICO, NXP, Corning, and Starbucks also feature on Q2 growth watchlists.
Apple's Third Co-Founder Sold His Stake for $800, No Regrets at 91
Ronald Wayne, Apple's forgotten co-founder, sold his 10% stake for $800 in 1976. Now worth nearly $400 billion, he says he has no regrets, emphasizing personal liability.
Dow Underperforms as Oil Surge, Fed, and Tech Earnings Loom
The Dow Jones Industrial Average slipped last week as oil prices climbed and investors await key earnings, the Fed decision, and economic data.
Infleqtion Under Pressure After Major Share Distribution by LCP Funds
Infleqtion shares dropped 5% after LCP Quantum-linked funds distributed over 30.5 million shares, removing their 10% owner status. The quantum tech firm reported $32.5M revenue and $35.3M loss.
Greg Abel's First Berkshire Meeting: $370B Cash Pile Under Spotlight
Greg Abel will make his debut as Berkshire Hathaway CEO at the annual meeting on May 2, with investors focused on the company's $370 billion cash pile and recent stock decline.
Old Republic International: Undervalued Amid Digital Transformation and Market Risks
Old Republic International (ORI) closed at $39.90, below its $42.50 fair value, as the insurer focuses on digitalization and AI to improve efficiency and margins. Risks include title insurance volatility and weaker real estate activity.
Microsoft's AI Spending Under Scrutiny Ahead of Q3 Earnings
Microsoft shares advanced 1.7% to $431.31 as Wall Street anticipates the company's upcoming earnings report, with particular attention on Azure performance and AI infrastructure investments. Bank of America reiterated its buy rating and $500 price target.
Stocks Retreat as Oil Surge, Fed Jitters Undercut Rally
Major U.S. equity indices turned lower Tuesday afternoon, surrendering morning advances as climbing crude prices and bond yields introduced fresh uncertainty. The S&P 500 declined 0.32% to 7,086.48.
Brent Crude Retreats Under $95 Amid U.S.-Iran Diplomacy Focus
Oil prices declined Tuesday, with Brent crude slipping below $95 per barrel, as traders shifted focus to potential diplomatic talks between the U.S. and Iran. This comes despite a major ongoing supply disruption in the Strait of Hormuz.
Hims & Hers Soars on FDA Catalyst as Omnicell Underperforms
Hims & Hers Health shares surged nearly 9% Monday, extending a strong weekly gain ahead of its May earnings report and a key FDA meeting on peptides. Omnicell reported mixed Q4 results with a net loss.
Market Pulse: Lynas Undervalued, Indian Indices Bullish, SpaceX Pre-IPO Routes
Lynas Rare Earths shows potential undervaluation despite recent volatility, while Indian benchmarks are poised for gains. Investors also eye pre-IPO access to SpaceX through indirect holdings.
Magnolia Oil & Gas Undervalued Despite Rally; BP, Regions Financial in Focus
Magnolia Oil & Gas stock appears deeply undervalued based on a DCF model, even after a strong year-to-date rally. Meanwhile, BP's valuation dips on recent share price weakness.
BASF, Evonik Show Undervaluation as Commodities React to Data
DCF analysis suggests BASF and Evonik Industries are trading at significant discounts to intrinsic value. Corn futures dipped despite strong exports, while cotton rallied. Indian equities opened higher on global cues.
Market Insights: Undervalued Stocks Emerge Amid Volatility
Financial analysis reveals potential undervaluation in Markel Group and Scotiabank, while the FTSE 100 correction boosts high-yield opportunities. Kinross Gold insider selling contrasts with analyst optimism.
Market Insights: CDW Undervalued, AI Investing Flaws, and Private AI Boom
A DCF analysis indicates CDW shares are undervalued by 18.4% despite recent weakness, while AI's role in investing faces scrutiny during market volatility. Anthropic garners intense interest in private secondary markets.